Billionaire Leon Cooperman Is Selling These 5 Stocks
In this article, we discuss the 5 stocks that billionaire Leon Cooperman is selling.
Anacor Pharmaceuticals Inc. (ANAC)
Market is closed
News
- 1 - 10
- Next >>
Here's Why Traders Are Buzzing about These Five Stocks on Monday
It's M&A Monday as Pfizer Inc. (NYSE:PFE), Anacor Pharmaceuticals Inc (NASDAQ:ANAC), Range Resources Corp.
Why Target, Movado, & Other Stocks Tumbled Today?
Major U.S. stock indexes are slightly in the red, dragged by the weak performance of several stocks. Among the top losers on Thursday are Silver Wheaton Corp.
Hedge Funds Are Glad They Sold Off These Stocks in Q4
During the fourth quarter, the smart money investment firms tracked by Insider Monkey were quick to withdraw their collective support from some well-known companies across various sectors, just before...
Palo Alto's Top Picks for This Year Following Impressive 2015 Returns
William Leland Edwards' Palo Alto Investors has about $2.22 billion worth of regulatory assets under its management.
Venrock's VHCP Management's Top Picks For 2016
At Insider Monkey, we look at the weighted average returns of the long positions a fund indicates in its 13F filings, in companies with a market cap greater than $1 billion, to estimate the returns of...
13G Filing: Baker Bros. Advisors and Anacor Pharmaceuticals, Inc. (ANAC)
According to a recent filing with the Securities and Exchange Commission, Julian and Felix Bakers' Baker Bros. Advisors are bullish on Anacor Pharmaceuticals Inc (NASDAQ:ANAC).
Top Stock Picks of Multi-Billion Dollar, Healthcare-Focused Fund Palo Alto Investors
Palo Alto Investors, founded by Wall Street veteran William Leland Edwards in 1989, is one of the biggest healthcare investment shops in the United States, with over $2 billion in assets under management...
Is Anacor Pharmaceuticals Inc (ANAC) A Good Stock To Buy?
The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive database.
VHCP Management Produced Impressive Returns From Its Pharma Stock Picks In The Turbulent Third Quarter
With losses in the high single-digits and volatility hitting the roof, the third quarter of 2015 turned out to be a troublesome period for the equity markets.
- 1 - 10
- Next >>
Billionaire Hedge Funds
